NFKBIA and rheumatoid arthritis: Previous studies have shown that under pathological conditions of RA, p‐p65 enhances NF‐κB activity, while p‐IκBα undergoes degradation, releasing NF‐κB to translocate into the nucleus and activate pro‐inflammatory gene expression.